Antagonistic SR proteins regulate alternative splicing of tumor-related Rac1b downstream of the PI3-kinase and Wnt pathways.
about
Posttranscriptional Regulation of Splicing Factor SRSF1 and Its Role in Cancer Cell BiologyConnecting the speckles: Splicing kinases and their role in tumorigenesis and treatment responseMolecular mechanisms of epithelial-mesenchymal transitionCell-context dependent TCF/LEF expression and function: alternative tales of repression, de-repression and activation potentialsIsolated pseudo-RNA-recognition motifs of SR proteins can regulate splicing using a noncanonical mode of RNA recognitionAlternative pre-mRNA splicing regulation in cancer: pathways and programs unhingedRegulation of Mcl-1 by SRSF1 and SRSF5 in cancer cellsDisturbed expression of splicing factors in renal cancer affects alternative splicing of apoptosis regulators, oncogenes, and tumor suppressorsTumor cell-derived MMP3 orchestrates Rac1b and tissue alterations that promote pancreatic adenocarcinoma.The RNAissance family: SR proteins as multifaceted regulators of gene expressionChemical treatment enhances skipping of a mutated exon in the dystrophin gene.Tumor cell expression of MMP3 as a prognostic factor for poor survival in pancreatic, pulmonary, and mammary carcinomaGenome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events.RBFOX2 is an important regulator of mesenchymal tissue-specific splicing in both normal and cancer tissues.Crosstalk between Wnt Signaling and RNA Processing in Colorectal Cancer.Novel signaling collaboration between TGF-β and adaptor protein Crk facilitates EMT in human lung cancer.Involvement of hnRNP A1 in the matrix metalloprotease-3-dependent regulation of Rac1 pre-mRNA splicing.Phosphorylation of SRSF1 by SRPK1 regulates alternative splicing of tumor-related Rac1b in colorectal cells.Alternative pre-mRNA splicing in digestive tract malignancy.Making alternative splicing decisions during epithelial-to-mesenchymal transition (EMT).Complex changes in alternative pre-mRNA splicing play a central role in the epithelial-to-mesenchymal transition (EMT).Regulation of splicing by SR proteins and SR protein-specific kinases.Hallmarks of alternative splicing in cancer.Epithelial-mesenchymal transition is regulated at post-transcriptional levels by transforming growth factor-β signaling during tumor progression.Rac1b enhances cell survival through activation of the JNK2/c-JUN/Cyclin-D1 and AKT2/MCL1 pathways.Epithelial splicing regulatory proteins 1 (ESRP1) and 2 (ESRP2) suppress cancer cell motility via different mechanisms.Cardiac glycosides correct aberrant splicing of IKBKAP-encoded mRNA in familial dysautonomia derived cells by suppressing expression of SRSF3.Insufficient ability of Rac1b to perturb cystogenesis.WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing.Alternative splicing of SLC39A14 in colorectal cancer is regulated by the Wnt pathway.Osteopontin-c isoform levels are associated with SR and hnRNP differential expression in ovarian cancer cell lines.Regulation of epithelial-mesenchymal transition in breast cancer cells by cell contact and adhesion.Both sides of the same coin: Rac1 splicing regulating by EGF signaling.Signaling Pathways Driving Aberrant Splicing in Cancer Cells.SRSF3 recruits DROSHA to the basal junction of primary microRNAs.Alternative splicing within the Wnt signaling pathway: role in cancer development.Multitasking β-catenin: from adhesion and transcription to RNA regulation
P2860
Q26798154-5FB8E44C-E691-46BA-A938-CA0C4EE6CE1DQ26824298-5718E3F4-4697-483E-8D56-E6C1E4F82D7CQ27013743-EAB4D21D-4A2E-455B-8997-63994BB3E37EQ27022532-9B530989-91E9-4B46-A252-6E7ECA8132DEQ27678986-182558C1-5F9F-4F20-9174-4AE5B8B36E60Q28297381-50EBEC50-3F8C-48CB-82F3-31A014EDCA8BQ28484403-2E03EC47-8CB4-4F22-87D2-769B32082CC0Q33748580-39DCFAA4-727A-4353-8284-D318C61FF3A5Q34364766-DFA4B15E-2FE2-48E7-9F98-1DA7EFE4B2D0Q34717851-661745ED-E0C9-4DEC-9352-3A7915403477Q35039875-3936265F-CEE2-4C1A-A3F7-D71BC6C17716Q36430125-835A1AB5-4B5B-452A-9A58-F93D594E5226Q36446169-CB3338C3-EBD0-4225-B48E-EF4136D936A0Q36559726-F973F2B2-AC60-4FC7-98A3-D1AE8E161309Q36583975-29492748-4262-4FF9-829A-3325EEDA45BFQ37317175-7886D979-BF35-4D4A-A03C-85EB14980A73Q37590130-A67044E3-A068-4FF3-90EA-FFDB143537D2Q37661658-F5DE6DF9-CCC9-47B5-835E-94485931036EQ37816501-C3176442-67A0-43DE-87EB-B387EC51873CQ37986326-7C3103F5-491B-4647-AA9C-62055BD3BC09Q38006770-8D645DE6-52A6-4C24-A61D-65CA81949A6BQ38092678-BB5A27BA-E547-4EA4-A36F-752A54C82270Q38171229-3B7F05B7-7844-4902-9C96-565CA60BC5DFQ38349021-917AD503-4FD6-4FEB-8AD7-745255FCAAEDQ38790849-46EB18EC-C0BA-4B0C-9241-A9EA5A63DB62Q38964131-7298D38B-6876-441D-B1DB-CC41EBFBAC1AQ39147059-99C1E21A-34F2-4A0E-92EB-D9D29FDA4891Q39194138-DDB09A84-5D50-4EE7-98F6-FD7658B8EF79Q39427761-AF87CEE8-31D1-4E64-919C-6D90743F99A6Q39645543-5BC1D3A2-3E67-4EDC-AC3F-87B4B627DE2FQ41932342-0207A202-BA14-4994-810F-DABF7F93BD59Q43144068-884825D0-228F-4520-87D4-8E95205BF127Q46795251-6FAB372A-8E23-4B15-865A-8FD7417E37DDQ47246029-C9E5728A-B73E-41E6-9802-A132CFC6A26EQ52333051-2E4C0AF2-4C9E-4AB1-ACBB-A4933F7B79E7Q53211105-D4A31E4F-2B07-4BB4-9BA2-2FA377B6E5F5Q58158336-5D328E43-F1AF-4754-95C4-1C8F3B33235A
P2860
Antagonistic SR proteins regulate alternative splicing of tumor-related Rac1b downstream of the PI3-kinase and Wnt pathways.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Antagonistic SR proteins regul ...... e PI3-kinase and Wnt pathways.
@en
Antagonistic SR proteins regul ...... e PI3-kinase and Wnt pathways.
@nl
type
label
Antagonistic SR proteins regul ...... e PI3-kinase and Wnt pathways.
@en
Antagonistic SR proteins regul ...... e PI3-kinase and Wnt pathways.
@nl
prefLabel
Antagonistic SR proteins regul ...... e PI3-kinase and Wnt pathways.
@en
Antagonistic SR proteins regul ...... e PI3-kinase and Wnt pathways.
@nl
P2093
P2860
P50
P356
P1476
Antagonistic SR proteins regul ...... he PI3-kinase and Wnt pathways
@en
P2093
Paulo Matos
Peter Jordan
Vânia Gonçalves
P2860
P304
P356
10.1093/HMG/DDP317
P577
2009-07-13T00:00:00Z